Tuesday, May 13, 2014

The Motley Fool: Alnylam Pharmaceuticals, Inc. Managing Multiple Irons In The Fire

Not only has the bloom left the rose of the biotech boom, investors have started plucking off the petals too. That has led to bowel-clenching declines for many biotechs, including Alnylam Pharmaceuticals (NASDAQ: ALNY  ) . While the market is going to do what it's going to do, Alnylam has an uncommonly deep pipeline, with multiple rare disease shots on goal and strong delivery technology in a therapeutic area where many Big Pharmas have thrown in the towel.

Read the full article here:
Alnylam Pharmaceuticals, Inc. Managing Multiple Irons In The Fire

No comments: